0 XP   0   0   0

BioSenic S.A.
Buy, Hold or Sell?

Should you buy, hold or sell Biosenic?

I guess you are interested in BioSenic S.A.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Biosenic

Let's start. I'm going to help you getting a better view of BioSenic S.A.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is BioSenic S.A. even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how BioSenic S.A. is doing in the market. If the company is worth buying. The latest step is to find out how other investors value BioSenic S.A.. The closing price on 2023-01-24 was €0.118 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
BioSenic S.A. Daily Candlestick Chart
BioSenic S.A. Daily Candlestick Chart
Summary









1. Valuation of Biosenic




Current price per share

€0.12

2. Growth of Biosenic




Is Biosenic growing?

Current yearPrevious yearGrowGrow %
How rich?-$7.3m$3.6m-$10.9m-149.2%

How much money is Biosenic making?

Current yearPrevious yearGrowGrow %
Making money-$14m-$13m-$1m-7.6%
Net Profit Margin-1,292.5%-1,194.0%--

How much money comes from the company's main activities?

3. Financial Health of Biosenic




Comparing to competitors in the Biotechnology industry




  Industry Rankings (Biotechnology)  



Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

1.1. Profitability of BioSenic S.A..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Biosenic earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Biosenic to the Biotechnology industry mean.
  • A Net Profit Margin of -1,292.5% means that €-12.93 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of BioSenic S.A.:

  • The MRQ is -1,292.5%. The company is making a huge loss. -2
  • The TTM is -1,292.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,292.5%TTM-1,292.5%0.0%
TTM-1,292.5%YOY-1,194.0%-98.5%
TTM-1,292.5%5Y-7,002.1%+5,709.6%
5Y-7,002.1%10Y-3,672.2%-3,330.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,292.5%-223.6%-1,068.9%
TTM-1,292.5%-281.7%-1,010.8%
YOY-1,194.0%-344.8%-849.2%
5Y-7,002.1%-450.1%-6,552.0%
10Y-3,672.2%-541.0%-3,131.2%
1.1.2. Return on Assets

Shows how efficient Biosenic is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biosenic to the Biotechnology industry mean.
  • -65.4% Return on Assets means that Biosenic generated €-0.65 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of BioSenic S.A.:

  • The MRQ is -65.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -65.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-65.4%TTM-65.4%0.0%
TTM-65.4%YOY-48.1%-17.3%
TTM-65.4%5Y-53.2%-12.2%
5Y-53.2%10Y-40.9%-12.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-65.4%-9.9%-55.5%
TTM-65.4%-8.9%-56.5%
YOY-48.1%-9.3%-38.8%
5Y-53.2%-11.7%-41.5%
10Y-40.9%-12.7%-28.2%
1.1.3. Return on Equity

Shows how efficient Biosenic is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biosenic to the Biotechnology industry mean.
  • 0.0% Return on Equity means Biosenic generated €0.00 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of BioSenic S.A.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-359.1%+359.1%
TTM-5Y-344.3%+344.3%
5Y-344.3%10Y-847.1%+502.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--12.0%+12.0%
TTM--11.5%+11.5%
YOY-359.1%-10.8%-348.3%
5Y-344.3%-14.2%-330.1%
10Y-847.1%-15.2%-831.9%

1.2. Operating Efficiency of BioSenic S.A..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Biosenic is operating .

  • Measures how much profit Biosenic makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biosenic to the Biotechnology industry mean.
  • An Operating Margin of -1,199.1% means the company generated €-11.99  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of BioSenic S.A.:

  • The MRQ is -1,199.1%. The company is operating very inefficient. -2
  • The TTM is -1,199.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-1,199.1%TTM-1,199.1%0.0%
TTM-1,199.1%YOY-1,118.4%-80.7%
TTM-1,199.1%5Y-6,666.5%+5,467.4%
5Y-6,666.5%10Y-3,489.8%-3,176.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,199.1%-207.3%-991.8%
TTM-1,199.1%-271.0%-928.1%
YOY-1,118.4%-325.9%-792.5%
5Y-6,666.5%-454.0%-6,212.5%
10Y-3,489.8%-537.1%-2,952.7%
1.2.2. Operating Ratio

Measures how efficient Biosenic is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 13.03 means that the operating costs are €13.03 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of BioSenic S.A.:

  • The MRQ is 13.026. The company is inefficient in keeping operating costs low. -1
  • The TTM is 13.026. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ13.026TTM13.0260.000
TTM13.026YOY16.017-2.991
TTM13.0265Y68.473-55.447
5Y68.47310Y35.822+32.651
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ13.0262.871+10.155
TTM13.0263.504+9.522
YOY16.0173.604+12.413
5Y68.4735.132+63.341
10Y35.8226.371+29.451

1.3. Liquidity of BioSenic S.A..

1.3. Liquidity
1.3.1. Current Ratio

Measures if Biosenic is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.14 means the company has €2.14 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of BioSenic S.A.:

  • The MRQ is 2.142. The company is able to pay all its short-term debts. +1
  • The TTM is 2.142. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.142TTM2.1420.000
TTM2.142YOY1.922+0.220
TTM2.1425Y1.661+0.480
5Y1.66110Y1.901-0.239
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1425.117-2.975
TTM2.1425.755-3.613
YOY1.9225.854-3.932
5Y1.6616.511-4.850
10Y1.9016.222-4.321
1.3.2. Quick Ratio

Measures if Biosenic is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biosenic to the Biotechnology industry mean.
  • A Quick Ratio of 2.17 means the company can pay off €2.17 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of BioSenic S.A.:

  • The MRQ is 2.172. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.172. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.172TTM2.1720.000
TTM2.172YOY1.888+0.283
TTM2.1725Y1.652+0.520
5Y1.65210Y1.813-0.161
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1724.284-2.112
TTM2.1724.664-2.492
YOY1.8884.787-2.899
5Y1.6525.218-3.566
10Y1.8135.182-3.369

1.4. Solvency of BioSenic S.A..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Biosenic assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biosenic to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.34 means that Biosenic assets are financed with 134.2% credit (debt) and the remaining percentage (100% - 134.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of BioSenic S.A.:

  • The MRQ is 1.342. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.342. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.342TTM1.3420.000
TTM1.342YOY0.866+0.476
TTM1.3425Y0.970+0.373
5Y0.97010Y0.910+0.060
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3420.278+1.064
TTM1.3420.277+1.065
YOY0.8660.306+0.560
5Y0.9700.367+0.603
10Y0.9100.403+0.507
1.4.2. Debt to Equity Ratio

Measures if Biosenic is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biosenic to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has €0.00 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of BioSenic S.A.:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY6.469-6.469
TTM-5Y6.140-6.140
5Y6.14010Y23.983-17.843
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.315-0.315
TTM-0.317-0.317
YOY6.4690.319+6.150
5Y6.1400.403+5.737
10Y23.9830.462+23.521

2. Market Valuation of BioSenic S.A.

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Biosenic generates.

  • Above 15 is considered overpriced but always compare Biosenic to the Biotechnology industry mean.
  • A PE ratio of -1.61 means the investor is paying €-1.61 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of BioSenic S.A.:

  • The EOD is -0.285. Company is losing money. -2
  • The MRQ is -1.609. Company is losing money. -2
  • The TTM is -1.609. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-0.285MRQ-1.609+1.324
MRQ-1.609TTM-1.6090.000
TTM-1.609YOY-6.800+5.191
TTM-1.6095Y-9.641+8.032
5Y-9.64110Y-10.995+1.355
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.285-8.986+8.701
MRQ-1.609-9.792+8.183
TTM-1.609-16.243+14.634
YOY-6.800-20.876+14.076
5Y-9.641-16.665+7.024
10Y-10.995-14.732+3.737
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Biosenic.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of BioSenic S.A.:

  • The MRQ is -1.754. Very Bad. -2
  • The TTM is -1.754. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-1.754TTM-1.7540.000
TTM-1.754YOY-7.920+6.166
TTM-1.7545Y-9.627+7.873
5Y-9.62710Y3.824-13.451
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.754-0.032-1.722
TTM-1.7540.004-1.758
YOY-7.9200.016-7.936
5Y-9.6270.006-9.633
10Y3.8240.003+3.821

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Biosenic is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -3.07 means the investor is paying €-3.07 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of BioSenic S.A.:

  • The EOD is -0.545. Bad. Book ratio is negative. -2
  • The MRQ is -3.074. Bad. Book ratio is negative. -2
  • The TTM is -3.074. Bad. Book ratio is negative. -2
Trends
Current periodCompared to+/- 
EOD-0.545MRQ-3.074+2.530
MRQ-3.074TTM-3.0740.000
TTM-3.074YOY24.412-27.487
TTM-3.0745Y42.006-45.080
5Y42.00610Y24.758+17.248
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.5451.835-2.380
MRQ-3.0742.006-5.080
TTM-3.0742.774-5.848
YOY24.4123.453+20.959
5Y42.0062.713+39.293
10Y24.7582.402+22.356
2. Total Gains per Share

2.4. Latest News of BioSenic S.A.

Does BioSenic S.A. still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from BioSenic S.A. to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2023-01-05
07:00
BioSenic SA : Information on the total number of voting rights and sharesRead

3. Summary

3.1. Key Performance Indicators

The key performance indicators of BioSenic S.A. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.323-0.3230%0.041-890%-0.141-56%-0.022-93%
Book Value Growth---2.034-2.0340%1.624-225%0.417-587%-15.883+681%
Book Value Per Share---0.217-0.2170%0.107-303%0.035-717%0.135-261%
Book Value Per Share Growth---2.034-2.0340%1.624-225%0.417-587%-15.883+681%
Current Ratio--2.1422.1420%1.922+11%1.661+29%1.901+13%
Debt To Asset Ratio--1.3421.3420%0.866+55%0.970+38%0.910+48%
Debt To Equity Ratio----0%6.469-100%6.140-100%23.983-100%
Dividend Per Share----0%-0%0.000-100%0.001-100%
Eps---0.414-0.4140%-0.382-8%-0.399-4%-0.330-20%
Eps Growth--0.9180.9180%0.859+7%0.989-7%0.794+16%
Free Cash Flow Per Share---0.416-0.4160%-0.518+25%-0.413-1%-0.344-17%
Free Cash Flow Per Share Growth--1.1971.1970%0.490+144%0.953+26%0.811+48%
Free Cash Flow To Equity Per Share---0.165-0.1650%-0.192+16%-0.146-11%-0.027-84%
Free Cash Flow To Equity Per Share Growth--1.1411.1410%-13.248+1261%-1.025+190%0.204+460%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---2.967--------
Intrinsic Value_10Y_min---2.582--------
Intrinsic Value_1Y_max---0.391--------
Intrinsic Value_1Y_min---0.380--------
Intrinsic Value_3Y_max---1.104--------
Intrinsic Value_3Y_min---1.044--------
Intrinsic Value_5Y_max---1.730--------
Intrinsic Value_5Y_min---1.595--------
Net Profit Margin---12.925-12.9250%-11.940-8%-70.021+442%-36.722+184%
Operating Margin---11.991-11.9910%-11.184-7%-66.665+456%-34.898+191%
Operating Ratio--13.02613.0260%16.017-19%68.473-81%35.822-64%
Pb Ratio-0.545+82%-3.074-3.0740%24.412-113%42.006-107%24.758-112%
Pe Ratio-0.285+82%-1.609-1.6090%-6.800+323%-9.641+499%-10.995+583%
Peg Ratio---1.754-1.7540%-7.920+352%-9.627+449%3.824-146%
Price Per Share0.118-464%0.6660.6660%2.600-74%3.836-83%4.646-86%
Price To Total Gains Ratio-0.365+82%-2.061-2.0610%63.534-103%12.523-116%8.542-124%
Profit Growth--0.9180.9180%0.859+7%0.989-7%0.783+17%
Quick Ratio--2.1722.1720%1.888+15%1.652+31%1.813+20%
Return On Assets---0.654-0.6540%-0.481-26%-0.532-19%-0.409-37%
Return On Equity----0%-3.5910%-3.4430%-8.4710%
Revenue Growth--1.0001.0000%--8.463-88%4.666-79%
Total Gains Per Share---0.323-0.3230%0.041-890%-0.141-56%-0.021-94%
Total Gains Per Share Growth---7.896-7.8960%2.523-413%-0.674-91%-0.044-99%
Usd Book Value---7367761.500-7367761.5000%3622346.600-303%1194524.880-717%4586853.560-261%
Usd Book Value Change Per Share---0.352-0.3520%0.045-890%-0.154-56%-0.024-93%
Usd Book Value Per Share---0.236-0.2360%0.116-303%0.038-717%0.147-261%
Usd Dividend Per Share----0%-0%0.000-100%0.001-100%
Usd Eps---0.451-0.4510%-0.416-8%-0.435-4%-0.359-20%
Usd Free Cash Flow---14148498.100-14148498.1000%-17616192.500+25%-14050696.920-1%-11712617.040-17%
Usd Free Cash Flow Per Share---0.453-0.4530%-0.564+25%-0.450-1%-0.375-17%
Usd Free Cash Flow To Equity Per Share---0.179-0.1790%-0.209+16%-0.159-11%-0.029-84%
Usd Price Per Share0.129-464%0.7250.7250%2.832-74%4.178-83%5.060-86%
Usd Profit---14076617.500-14076617.5000%-13003854.000-8%-13569314.720-4%-11210215.210-20%
Usd Revenue--1089100.0001089100.0000%1089100.0000%662390.620+64%757795.780+44%
Usd Total Gains Per Share---0.352-0.3520%0.045-890%-0.153-56%-0.023-94%
 EOD+2 -3MRQTTM+0 -0YOY+15 -215Y+11 -2910Y+16 -24

3.2. Fundamental Score

Let's check the fundamental score of BioSenic S.A. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.285
Price to Book Ratio (EOD)Between0-1-0.545
Net Profit Margin (MRQ)Greater than0-12.925
Operating Margin (MRQ)Greater than0-11.991
Quick Ratio (MRQ)Greater than12.172
Current Ratio (MRQ)Greater than12.142
Debt to Asset Ratio (MRQ)Less than11.342
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.654
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of BioSenic S.A. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.395
Ma 20Greater thanMa 500.114
Ma 50Greater thanMa 1000.126
Ma 100Greater thanMa 2000.157
OpenGreater thanClose0.133
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2017-12-312018-12-312019-12-312020-12-312021-12-31
Total Stockholder Equity 2,3832,1084,491-2,4432,0481,2773,325-10,090-6,765
Net Tangible Assets  2,3532,1164,469-2,4492,0201,2773,297-10,086-6,789



Latest Balance Sheet

Balance Sheet of 2021-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets19,772
Total Liabilities26,537
Total Stockholder Equity-6,765
 As reported
Total Liabilities 26,537
Total Stockholder Equity+ -6,765
Total Assets = 19,772

Assets

Total Assets19,772
Total Current Assets14,291
Long-term Assets14,291
Total Current Assets
Cash And Cash Equivalents 9,510
Short-term Investments 1,200
Net Receivables 2,581
Total Current Assets  (as reported)14,291
Total Current Assets  (calculated)13,291
+/- 1,000
Long-term Assets
Property Plant Equipment 863
Intangible Assets 23
Other Assets 4,582
Long-term Assets  (as reported)5,481
Long-term Assets  (calculated)5,468
+/- 13

Liabilities & Shareholders' Equity

Total Current Liabilities6,673
Long-term Liabilities19,864
Total Stockholder Equity-6,765
Total Current Liabilities
Short-term Debt 1,046
Short Long Term Debt 945
Accounts payable 4,502
Other Current Liabilities 1,125
Total Current Liabilities  (as reported)6,673
Total Current Liabilities  (calculated)7,618
+/- 945
Long-term Liabilities
Long term Debt 19,243
Capital Lease Obligations 610
Other Liabilities 112
Long-term Liabilities Other 112
Long-term Liabilities  (as reported)19,864
Long-term Liabilities  (calculated)20,077
+/- 213
Total Stockholder Equity
Common Stock4,924
Retained Earnings -81,488
Other Stockholders Equity 69,799
Total Stockholder Equity (as reported)-6,765
Total Stockholder Equity (calculated)-6,765
+/-0
Other
Capital Stock4,924
Cash and Short Term Investments 10,710
Common Stock Shares Outstanding 11,723
Liabilities and Stockholders Equity 19,772
Net Debt 11,288
Net Invested Capital 13,423
Net Tangible Assets -6,789
Net Working Capital 7,618
Short Long Term Debt Total 20,798



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
> Total Assets 
15,053
14,418
12,811
24,201
50,383
38,585
25,173
25,754
22,393
24,836
19,772
19,77224,83622,39325,75425,17338,58550,38324,20112,81114,41815,053
   > Total Current Assets 
13,049
11,767
8,087
19,259
41,701
28,471
14,615
15,000
11,733
18,817
14,291
14,29118,81711,73315,00014,61528,47141,70119,2598,08711,76713,049
       Cash And Cash Equivalents 
5,559
4,822
2,440
11,576
33,611
20,300
8,411
8,174
8,633
14,648
9,510
9,51014,6488,6338,1748,41120,30033,61111,5762,4404,8225,559
       Short-term Investments 
203
0
0
0
0
0
0
0
0
0
1,200
1,200000000000203
       Net Receivables 
0
6,834
5,513
7,498
9
8,013
5,938
6,724
3,025
3,840
2,581
2,5813,8403,0256,7245,9388,01397,4985,5136,8340
       Other Current Assets 
7,287
6,945
5,647
7,683
8,090
8,171
6,204
6,826
3,100
4,169
3,581
3,5814,1693,1006,8266,2048,1718,0907,6835,6476,9457,287
   > Long-term Assets 
2,004
2,651
4,724
4,942
8,682
10,114
10,558
10,754
10,660
6,019
5,481
5,4816,01910,66010,75410,55810,1148,6824,9424,7242,6512,004
       Property Plant Equipment 
1,137
1,277
2,869
2,667
5,793
6,385
6,302
6,203
6,100
226
863
8632266,1006,2036,3026,3855,7932,6672,8691,2771,137
       Long Term Investments 
0
0
282
283
282
291
297
326
472
0
0
0047232629729128228328200
       Intangible Assets 
0
19
60
53
69
56
30
22
28
28
23
232828223056695360190
       Long-term Assets Other 
204
428
462
463
487
590
615
648
473
1,309
5,783
5,7831,309473648615590487463462428204
> Total Liabilities 
11,241
11,780
12,748
33,687
22,236
23,315
22,790
21,262
20,345
21,510
26,537
26,53721,51020,34521,26222,79023,31522,23633,68712,74811,78011,241
   > Total Current Liabilities 
6,400
5,854
6,246
26,359
10,543
10,513
10,598
9,327
9,339
9,790
6,673
6,6739,7909,3399,32710,59810,51310,54326,3596,2465,8546,400
       Short-term Debt 
152
192
509
13,116
2,314
1,242
1,251
2,605
2,709
3,077
1,046
1,0463,0772,7092,6051,2511,2422,31413,116509192152
       Short Long Term Debt 
0
0
5,561
427
2,280
1,048
1,130
2,499
2,531
3,045
945
9453,0452,5312,4991,1301,0482,2804275,56100
       Accounts payable 
789
1,116
1,136
2,853
1,818
2,327
2,808
3,242
3,069
5,171
4,502
4,5025,1713,0693,2422,8082,3271,8182,8531,1361,116789
       Other Current Liabilities 
5,459
4,546
4,601
10,390
6,411
6,944
6,539
3,469
3,561
1,542
1,125
1,1251,5423,5613,4696,5396,9446,41110,3904,6014,5465,459
   > Long-term Liabilities 
4,841
5,926
6,502
7,328
11,693
12,802
12,192
11,935
11,006
11,720
19,864
19,86411,72011,00611,93512,19212,80211,6937,3286,5025,9264,841
       Long term Debt Total 
0
0
0
0
10,118
11,167
10,551
10,247
11,006
0
0
0011,00610,24710,55111,16710,1180000
       Other Liabilities 
0
1,812
1,450
1,501
1,575
1,636
1,641
1,678
0
0
112
112001,6781,6411,6361,5751,5011,4501,8120
> Total Stockholder Equity
3,812
2,637
63
-9,485
28,147
15,270
2,383
4,491
2,048
3,325
-6,765
-6,7653,3252,0484,4912,38315,27028,147-9,485632,6373,812
   Common Stock
6,943
8,417
9,288
10,466
20,708
20,708
14,663
12,532
5,454
8,415
4,924
4,9248,4155,45412,53214,66320,70820,70810,4669,2888,4176,943
   Retained Earnings -81,488-73,080-61,586-62,136-55,501-48,773-35,752-21,670-15,860-11,794-8,097
   Accumulated Other Comprehensive Income 00-4,283-3,544-2,983-2,497-2,013-1,656-1,315-939-546
   Capital Surplus 
0
0
0
0
42,670
42,670
42,665
53,478
58,026
0
0
0058,02653,47842,66542,67042,6700000
   Treasury Stock00000000000
   Other Stockholders Equity 
5,512
6,953
7,950
3,375
45,204
45,832
46,204
57,639
62,463
67,990
69,799
69,79967,99062,46357,63946,20445,83245,2043,3757,9506,9535,512



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue1,000
Cost of Revenue--
Gross Profit-1,000
 
Operating Income (+$)
Gross Profit-
Operating Expense-13,026
Operating Income-12,026-13,026
 
Operating Expense (+$)
Research Development11,684
Selling General Administrative1,768
Selling And Marketing Expenses-
Operating Expense13,02613,452
 
Net Interest Income (+$)
Interest Income358
Interest Expense-845
Net Interest Income-789-487
 
Pretax Income (+$)
Operating Income-12,026
Net Interest Income-789
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-12,836-11,216
EBIT - interestExpense = -12,836
-12,836
-12,080
Interest Expense845
Earnings Before Interest and Taxes (ebit)-11,991-11,991
Earnings Before Interest and Taxes (ebitda)-11,805
 
After tax Income (+$)
Income Before Tax-12,836
Tax Provision-89
Net Income From Continuing Ops-12,925-12,925
Net Income-12,925
Net Income Applicable To Common Shares-12,925
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses13,026
Total Other Income/Expenses Net-810789
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
KLV.CC
1 minute ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of KLV.CC.

KLV.CC Daily Candlestick Chart
KIT.CC
1 minute ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of KIT.CC.

KIT.CC Daily Candlestick Chart
KLAY.CC
1 minute ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of KLAY.CC.

KLAY.CC Daily Candlestick Chart
KGC.CC
2 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of KGC.CC.

KGC.CC Daily Candlestick Chart
KDAG.CC
3 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of KDAG.CC.

KDAG.CC Daily Candlestick Chart
KAVA.CC
3 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of KAVA.CC.

KAVA.CC Daily Candlestick Chart
JEWEL.CC
5 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of JEWEL.CC.

JEWEL.CC Daily Candlestick Chart
JAR.CC
5 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of JAR.CC.

JAR.CC Daily Candlestick Chart
JADE.CC
6 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of JADE.CC.

JADE.CC Daily Candlestick Chart
IRIS.CC
6 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of IRIS.CC.

IRIS.CC Daily Candlestick Chart
IPL.CC
7 minutes ago

I found you a RSI Bearish Reversal Divergence on the daily chart of IPL.CC.

IPL.CC Daily Candlestick Chart
IOTX.CC
8 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of IOTX.CC.

IOTX.CC Daily Candlestick Chart
IMT.CC
9 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of IMT.CC.

IMT.CC Daily Candlestick Chart
IDEA.CC
11 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of IDEA.CC.

IDEA.CC Daily Candlestick Chart
IBP.CC
12 minutes ago

I found you a MACD Bearish Hidden Divergence on the daily chart of IBP.CC.

IBP.CC Daily Candlestick Chart
HVN.CC
13 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of HVN.CC.

HVN.CC Daily Candlestick Chart
HUNT.CC
13 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of HUNT.CC.

HUNT.CC Daily Candlestick Chart
HTDF.CC
14 minutes ago

I found you a MACD Bullish Hidden Divergence on the daily chart of HTDF.CC.

HTDF.CC Daily Candlestick Chart
HPS.CC
15 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of HPS.CC.

HPS.CC Daily Candlestick Chart
HOT1.CC
15 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of HOT1.CC.

HOT1.CC Daily Candlestick Chart
HOGE.CC
16 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of HOGE.CC.

HOGE.CC Daily Candlestick Chart
HIVE.CC
16 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of HIVE.CC.

HIVE.CC Daily Candlestick Chart
HBDC.CC
18 minutes ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of HBDC.CC.

HBDC.CC Daily Candlestick Chart
GUM.CC
20 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of GUM.CC.

GUM.CC Daily Candlestick Chart
GTC.CC
20 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of GTC.CC.

GTC.CC Daily Candlestick Chart